(NOT) BUSINESS AS USUAL
At Commercial Eyes, we focus our efforts on supporting clients in the regulated therapeutics industry get their products to the patients who need them, when they need…
Latest News
ARCS Australia appoints Commercial Eyes Founder and Managing Director to Board.
ARCS Australia has appointed Commercial Eyes Founder and Managing Director, Andrew Carter, to its Board of…
Educating and empowering Indigenous children through Yalari
Commercial Eyes is honoured to be able to provide ongoing support to educating Indigenous children through…
Leukaemia Foundation – Raising Awareness of Blood Cancers
Through various parts of our business including market access and insights, regulatory services and medical communications, Commercial Eyes works with a number of organisations involved in improving and extending the…
No CE mark? No problem.
Changes to legislation have increased flexibility for Sponsors looking to market medical devices in…
Are you ready for the mandatory transition to eCTD for prescription medicines?
A staged implementation has been proposed for prescription medicines to reflect the current industry uptake of the eCTD format. The transition begins with new chemical entity, new biological entity, biosimilar…
The long road to PBS listing for Orkambi
With its recent stint on Sunrise, Orkambi is a high-profile example of what can occur when both the PBAC and the sponsor are unable to reach agreement on the value of a…
New ‘SmPC’ Format for the Australian Product Information
The TGA have published a new form for providing the product information (PI) which means more work for regulatory teams but an enhancement of the quality use of medicines for Australian patients….
Commercial Eyes has a Victorian Poisons and Controlled Substances Licence
The licence facilitates our Regulatory Services department’s product complaints investigations work and enables our Medical Services team to reference the physical product when responding to medical enquiries from patients and…